An examination of antibacterial and antifungal properties of constituents of Shiitake (Lentinula edodes) and Oyster (Pleurotus ostreatus) mushrooms
Tài liệu tham khảo
Wasser SP. Encyclopedia of dietary supplements 2005:653–4. doi:10.1081/E-EDS-120024880.
Chang, 1996, Mushroom nutriceuticals, World J Microbiol Biotechnol, 12, 473, 10.1007/BF00419460
Maeda, 1998, Four dominant loci for the vascular responses by the antitumor polysaccharide, lentinan, Immunogenetics, 47, 159, 10.1007/s002510050341
Ng, 2002, Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes), J Altern Complement Med, 581, 10.1089/107555302320825093
Ngai, 2003, Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells, Life Sci, 73, 3363, 10.1016/j.lfs.2003.06.023
Komemushi, 1995, Antimicrobial substance produced by Lentinus edodes, J Antibacterial Antifungal Agents, 23, 81
Komemushi, 1996, Purification and identification of antimicrobial substances produced by Lentinus edodes, J Antibacterial Antifungal Agents, 24, 21
Hatvani, 2001, Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture, Int J Antimicrob Agents, 17, 71, 10.1016/S0924-8579(00)00311-3
Ishikawa, 2001, Antibacterial activity of Lentinula edodes, Braz J Microbiol, 32, 206, 10.1590/S1517-83822001000300008
Sugiyama, 1995, Eritadenine-induced alteration of hepatic phospholipid metabolism in relation to its hypocholesterolemic action in rats, Nutrit Biochem, 6, 80, 10.1016/0955-2863(94)00017-G
Yang, 2002, Hypoglycemic effect of a Lentinus edodes exo-polymer produced from a submerged mycelial culture, Biosci Biotechnol Biochem, 66, 937, 10.1271/bbb.66.937
Kathatun, 2007, Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects, Mymensingh Med J, 16, 94
Maeda, 2007, Antibacterial activity of honey against community associated methicillin-resistant Staphylococcus aureus (CA-MRSA), Complement Ther Clin Pract, 14, 77, 10.1016/j.ctcp.2007.11.004